investigated whether NOD2-deficient mice are sensitive to NASH-associated liver cancer and showed that upon the treatment with DMBA and consumption of HFD, NOD2-deficient mice gained more weight and bore more HCC tumors than NOD2-intact mice (45). Here, NOD2 is linked to hepatocellular carcinoma.